NCT03672383View on ClinicalTrials.gov

Functional Study to Investigate the Efficacy of a New Medical Device (Modified Diprobase Formulation)

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 17, 2018

Primary Completion Date

October 17, 2018

Study Completion Date

October 17, 2018

Conditions
Dermatitis, Atopic
Interventions
DEVICE

BAY987534

Form: cream; Route of Administration: topical; Frequency of Administration: twice daily ; Duration of Treatment: 4 weeks .

Trial Locations (1)

22869

proDerm, Hamburg

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT03672383 - Functional Study to Investigate the Efficacy of a New Medical Device (Modified Diprobase Formulation) | Biotech Hunter | Biotech Hunter